Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ZYMERON CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-07-11 to 2024-11-10
Current total value of award: $1100000
Description: AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "NOVEL ANTIBIOTICS TARGETING MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA INFECTIONS"